Hydrea
500mg
Developed to alleviate conditions involving abnormal blood cell growth to address long-term stability and symptom control.
500mg
Developed to alleviate conditions involving abnormal blood cell growth to address long-term stability and symptom control.
500mg
Formulated to target cancerous cell growth and indicated to support blood count regulation, this agent is utilized to manage specific haematologic conditions.